dapi s7113 (Merck KGaA)
90
Structured Review
Merck KGaA
dapi s7113
Dapi S7113, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapi+solution/dapi+containing+antifade+solution+s7113/pm30927362-97-10-12
Average 90 stars, based on 1 article reviews
Dapi S7113, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dapi+solution/dapi+containing+antifade+solution+s7113/pm30927362-97-10-12
Average 90 stars, based on 1 article reviews
dapi s7113 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [ 52 Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model. Article Snippet: For nuclear counterstaining DAPI, (MBD0020; DAPI ready-made solution with Article Title: MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression. Article Snippet: MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression JELENA RONCEVIC, ILONA DJORIC, SONJA SELEMETJEV, JELENA JANKOVIC, TIJANA ISIC DENCIC, VESNA BOZIC, DUBRAVKA CVEJIC 1Institute for the Application of Nuclear Energy-INEP, University of Belgrade, Belgrade, Serbia; 2Clinical Centre of Serbia, Department of Endocrine and Cardiovascular Pathology, Belgrade, Serbia Article Title: Impact of PD‑L1 upregulation on immune checkpoint inhibitor efficacy in triple‑negative breast cancer using a 4T1 murine model. Article Snippet: Nuclei were counterstained with Article Title: CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas. Article Snippet: Objectives Gene products, which show a significant association to cell proliferation and cell cycle control, are of high scientific interest, because genes as well as gene products could be possible targets for a specific therapeutic approach and eventually be prognostic markers.. Materials and methods Cyclin D1 expression and amplification as well as the Ki-67 expression status were examined in a two tissue microarray analysis for head and neck squamous cell carcinoma (HNSCC) including 546 patients.. A tumour site-specific analysis and a survival analysis of 222 oral squamous cell carcinoma (OSCC) patients were performed. Article Title: Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration. Article Snippet: After subsequent washes in PBS, brain slices were incubated with Article Title: Impact of PD-L1 upregulation on immune checkpoint inhibitor efficacy in triple-negative breast cancer using a 4T1 murine model Article Snippet: Cells were incubated overnight at 4°C with a fluorescence-conjugated anti-PD-L1 antibody (1:200; cat. no. MAB90782AF647; Novus Biologicals, LLC) diluted in blocking buffer. Incubation:Article Title: Plasmodium knowlesi Duffy binding protein alpha region II (PkDBPαII) in clinical isolates from Peninsular Malaysia and Malaysian Borneo exhibit different immune responses in animal models. Article Snippet: Plasmodium knowlesi utilizes the Duffy binding protein alpha (PkDBPα) to facilitate its invasion into human erythrocytes.. PkDBPα region II (PkDBPαII) from Peninsular Malaysia and Malaysian Borneo has been shown to occur as distinct haplotypes, and the predominant haplotypes from these geographical areas demonstrated differences in binding activity to human erythrocytes in erythrocyte binding assays.. This study aimed to determine the effects of genetic polymorphisms in PkDBPαII to immune responses in animal models. Article Title: Inhibition of Plasmodium knowlesi merozoite invasion into human erythrocytes by antibodies raised against the parasite's secreted protein with altered thrombospondin repeat (SPATR). Article Snippet: Received: 15 December 2023 Revised: 4 March 2024 Accepted: 5 Mach 2024 Published: 30 June 2024 The Plasmodium secreted protein with an altered thrombospondin repeat (SPATR) has been known to play an important role in the malaria parasite’s invasion into host erythrocytes.. This protein is immunogenic and has been considered as one of the potential vaccine candidates against malaria parasite infection.. Thus far, only a handful immunological studies have been carried out on P. knowlesi SPATR (PkSPATR), and none of these studies investigated the immunoprotective properties of the protein. |
